How Erections Work: The Physiology of Penile Erection

The Basics: A Hydraulic System

At its most fundamental level, an erection is a hydraulic event. The penis transitions from a flaccid to a rigid state through the controlled inflow of arterial blood into expandable tissue spaces, combined with the restriction of venous outflow that would normally drain that blood away. The result is pressurized engorgement — the erectile bodies fill with blood, expand against their fibrous casing, and produce mechanical stiffness.

This process is remarkably precise. It requires coordinated input from the nervous system, properly functioning blood vessels, healthy smooth muscle tissue, intact fascial structures, and an appropriate hormonal environment. A disruption at any point in this chain can impair erectile function — which is why erectile dysfunction (ED) has so many potential causes.[1]

For an overview of the structures involved, see Penile Anatomy: A Medical Guide.

The Three Phases of Erection

Initiation: Nerve Signaling

Erection begins with stimulation — either psychogenic (originating in the brain from visual, auditory, or imaginative stimuli) or reflexogenic (originating from direct physical stimulation of the genitals). Both pathways ultimately converge on the cavernous nerves, which travel from the pelvic plexus to the corpora cavernosa.

When the cavernous nerves are activated, their nerve terminals release neurotransmitters — most importantly nitric oxide (NO) and acetylcholine — at the smooth muscle cells lining the arterial walls and sinusoidal spaces of the corpora cavernosa. This chemical signaling is the trigger that starts the filling process.[2]

Tumescence: Filling and Trapping

Once nitric oxide reaches the smooth muscle cells, it activates an enzyme called guanylate cyclase, which increases levels of a molecule called cyclic GMP (cGMP). Cyclic GMP causes the smooth muscle to relax — and this relaxation is the critical event that makes erection possible.

When the smooth muscle in the walls of the helicine arteries (the small arteries within the corpora cavernosa) relaxes, these arteries dilate, dramatically increasing blood flow into the sinusoidal spaces. Simultaneously, the smooth muscle lining the sinusoids themselves relaxes, allowing the spaces to expand and fill with blood.

As the sinusoids expand, they compress the subtunical venous plexus — the network of small veins that normally drains blood from the erectile tissue — against the inner surface of the tunica albuginea. This compression restricts outflow, creating a one-way valve effect: blood flows in but cannot easily flow out. Intracavernosal pressure rises to approximately 100 mmHg, producing full rigidity.[1]

This trapping mechanism is called the corporeal veno-occlusive mechanism, and it is one of the most elegant examples of functional anatomy in the human body. The tunica albuginea — described in detail in the anatomy article — is the structural element that makes it work.

Detumescence: Return to Flaccid

Erection is not a permanent state because the body actively terminates it through a process called detumescence. This occurs when sympathetic nerve signals cause the release of norepinephrine, which contracts the smooth muscle of the arteries and sinusoids. An enzyme called phosphodiesterase type 5 (PDE5) also breaks down cGMP, removing the chemical signal that was maintaining smooth muscle relaxation.

As smooth muscle contracts, the arteries narrow, blood inflow decreases, and the sinusoids shrink. This releases the compression on the veins, allowing trapped blood to drain out through the venous system. The penis returns to its flaccid state.[2]

This is the mechanism that PDE5 inhibitor medications target. By blocking the enzyme that breaks down cGMP, these medications prolong smooth muscle relaxation and make it easier to achieve and maintain an erection. They do not create erection on their own — they enhance the body's natural response to sexual stimulation.

The Nitric Oxide Pathway

Nitric oxide (NO) deserves special attention because it is the central mediator of erection. NO is produced by the enzyme nitric oxide synthase (NOS), which exists in both nerve terminals (neuronal NOS) and the endothelial cells lining blood vessels (endothelial NOS). Both sources contribute to the erectile response.[3]

Any condition that impairs NO production or availability can contribute to erectile dysfunction. This includes vascular disease (which damages endothelial cells), diabetes (which affects both nerves and blood vessels), smoking (which reduces NO bioavailability), and aging (which is associated with decreased NOS activity). Understanding this pathway helps explain why cardiovascular health and erectile health are closely linked — they depend on the same fundamental vascular biology.

Types of Erection

Not all erections are triggered the same way, and understanding the different types helps clarify the neurological pathways involved:

• Psychogenic erections are initiated by the brain in response to visual, auditory, olfactory, or imaginative stimuli. Signals travel from the cerebral cortex through the spinal cord to the cavernous nerves. These are mediated by the thoracolumbar spinal segments (T11-L2).
• Reflexogenic erections are triggered by direct physical stimulation of the genitals. Sensory signals travel via the pudendal nerve to the sacral spinal cord (S2-S4), which activates a reflex arc that sends erectile signals back through the cavernous nerves. These can occur even in some men with spinal cord injuries above the sacral level.
• Nocturnal erections occur during REM sleep and are thought to be associated with central nervous system activation during dreaming. Most healthy men experience 3-5 nocturnal erections per night, each lasting 25-35 minutes. The presence of nocturnal erections is sometimes used diagnostically to distinguish psychogenic from organic ED.[4]

What Can Go Wrong

Erectile dysfunction — the inability to achieve or maintain an erection sufficient for satisfactory sexual activity — is common, affecting an estimated 30 million men in the United States alone. The causes can be categorized by which part of the erectile pathway is affected:

• Vascular causes — atherosclerosis, hypertension, diabetes, and other conditions that damage blood vessels or reduce blood flow. This is the most common category of organic ED.
• Neurological causes — spinal cord injury, multiple sclerosis, pelvic surgery (especially prostatectomy), diabetic neuropathy, and other conditions that disrupt nerve signaling.
• Hormonal causes — low testosterone (hypogonadism), thyroid disorders, and hyperprolactinemia can affect libido and erectile response.
• Structural causes — Peyronie's disease (fibrous plaque within the tunica albuginea) can impair the veno-occlusive mechanism and cause painful, curved erections.
• Psychological causes — performance anxiety, depression, relationship issues, and stress can impair the psychogenic component of erection, particularly in younger men.[5]

Many men experience ED from a combination of these factors. A thorough evaluation by a healthcare provider is important for identifying the underlying cause and determining appropriate treatment.

Neuromodulators and Erectile Function

An emerging area of interest in penile medicine involves the use of neuromodulator injections (botulinum toxin) in the corpus cavernosum smooth muscle. The rationale is that by partially relaxing the smooth muscle of the erectile bodies, the retraction reflex — the tendency of the penis to retract toward the body, particularly in cold or stressful conditions — can be reduced.

Clinical experience from providers offering this treatment suggests that many patients see improvements in flaccid hang and reduced retraction, and some patients report decreased reliance on erectile dysfunction medications. The effect is temporary, typically lasting approximately six months. This approach targets a different mechanism than filler-based girth enhancement and can be used independently or in combination. For more detail, see Penile Neuromodulator Injection.[6]

Why Enhancement Does Not Affect Erections

Patients considering filler-based girth enhancement often ask whether the procedure will affect their ability to achieve or maintain erections. The answer, when the procedure is performed correctly, is no — and the anatomy explains why.

The erectile mechanism occurs entirely within the corpora cavernosa, which are deep structures surrounded by the tunica albuginea and Buck's fascia. Filler placed in the subdermal plane — the space between the skin and dartos fascia — sits in a tissue layer that is entirely superficial to the erectile bodies. There is no anatomical pathway by which subdermal filler would compress, obstruct, or otherwise interfere with the vascular filling and trapping mechanism that produces erection.[7]

This is one of the key safety advantages of the subdermal technique: by working in the most superficial plane, it maintains the greatest distance from the neurovascular structures and erectile bodies that underlie normal sexual function. For a detailed comparison of injection planes, see Subdermal vs Traditional Injection.

Frequently Asked Questions

What causes an erection?

An erection is caused by increased blood flow into the corpora cavernosa combined with restricted venous outflow. Sexual stimulation triggers nitric oxide release, which relaxes smooth muscle, allowing blood to fill the sinusoidal spaces. As these expand, they compress veins against the tunica albuginea, trapping blood and producing rigidity.

Does penile filler affect erections?

When properly placed in the subdermal tissue plane, filler does not interfere with the erectile mechanism. The erectile bodies and their blood supply lie in deeper tissue layers. Filler placed superficially adds girth without affecting the internal hydraulic process of erection.

Why does the penis retract in cold conditions?

The dartos fascia contains smooth muscle that contracts in response to cold, pulling the penile and scrotal skin closer to the body to conserve heat. This is a normal physiological response and does not affect erectile capacity. Neuromodulator injections can reduce this retraction reflex for patients who find it bothersome.

For clinicians: penis filler training and certification.